Takis’ Post

View organization page for Takis, graphic

7,079 followers

A new cellular #immunotherapy approach may be effective in treating metastatic solid #tumors! An important finding this July has been made by the National Institutes of Health, which reported early findings from a clinical trial. In the experiment, researchers from the National Institutes of Health (NIH) genetically engineered normal lymphocytes from each patient to produce receptors that recognize and attack their specific cancer cells. According to Steven A. Rosenberg, M.D., Ph.D., of NCI’s Center for Cancer Research (CCR): “the fact that we can take a growing metastatic solid cancer and get it to regress shows that the new cellular immunotherapy approach has promise. However, it’s important to understand that these findings are preliminary and that the approach needs to be further refined and tested.” As Takis, we are focused on every step Immunotherapy takes in science to propose new solutions and progress with our research and services. We are committed to develop our own immunotherapy products as well as support other Pharma companies that want to test new immunotherapies with our in vitro and in vivo models. If you want to know more about our services on Immunotherapy please contact us here on LinkedIn!

Immunotherapy approach shows potential in some people with metastatic solid tumors

Immunotherapy approach shows potential in some people with metastatic solid tumors

nih.gov

To view or add a comment, sign in

Explore topics